Rintis Medikamentosa dalam Praktik Klinis: Diagnosis, Terapi, dan Pencegahan – A Narrative Review

Authors

  • Nafisa Nathania Rema Putri Universitas Muhammadiyah Surakarta
  • Fadea Zahrotul Istiwa Universitas Muhammadiyah Surakarta
  • Rana Aqila Universitas Muhammadiyah Surakarta
  • Rafi Sandi Putra Pratama Universitas Muhammadiyah Surakarta
  • Sa’idatul Fithriyah Universitas Muhammadiyah Surakarta

DOI:

https://doi.org/10.31004/riggs.v4i4.4265

Keywords:

Rinitis Medikamentosa, Dekongestan Topikal, Diagnosis, Terapi , Pencegahan

Abstract

Rinitis Medikamentosa (RM) merupakan bentuk rinitis non-alergi yang muncul akibat penggunaan kronis dekongestan topikal dan ditandai oleh obstruksi nasal persisten, perubahan histopatologis pada mukosa, serta risiko ketergantungan yang dapat memperburuk gejala dari waktu ke waktu. Narrative review ini bertujuan meninjau secara komprehensif aspek diagnosis, terapi, serta upaya pencegahan RM berdasarkan literatur terkini. Penelusuran artikel dilakukan melalui PubMed dan Google Scholar pada rentang tahun 2015–2025 dan menghasilkan 62 artikel, dengan 10 di antaranya memenuhi kriteria inklusi dan dianalisis lebih lanjut. Hasil telaah menunjukkan bahwa diagnosis RM terutama ditegakkan melalui anamnesis mengenai riwayat penggunaan dekongestan berlebihan, disertai pemeriksaan fisik yang umumnya memperlihatkan kongesti nasal difus, edema mukosa, dan eritema yang dapat dikonfirmasi melalui rinoskopi. Faktor risiko yang berkontribusi mencakup kebiasaan merokok, inflamasi mukosa kronis, paparan iritan lingkungan, serta kondisi psikologis tertentu yang mendorong penggunaan obat secara berulang. Tata laksana utama RM adalah penghentian dekongestan secara bertahap atau total, yang kemudian ditunjang dengan pemberian kortikosteroid intranasal, irigasi saline, serta intervensi bedah pada kasus refrakter yang tidak merespons terapi konservatif. Selain itu, edukasi pasien mengenai penggunaan obat yang benar, potensi efek samping, serta strategi pencegahan kekambuhan menjadi komponen penting dalam upaya menekan angka kejadian RM. Kombinasi pendekatan farmakologis, non-farmakologis, edukatif, dan prosedural menjadi strategi paling rasional dan efektif dalam tata laksana komprehensif RM.

Downloads

Download data is not yet available.

References

B Wahid NW, Carl S. Rhinitis Medicamentosa. StatPearls Publishing; 2023.

Birinci M, Ozdemir D, Pusuroglu M, Sevim Ö, Yemiş T, Cihan SN, et al. Rhinitis medicomentosa and substance addiction. European Archives of Oto-Rhino-Laryngology 2024. https://doi.org/10.1007/s00405-024-08723-9.

Cam B, Sari M, Midi A, Gergin O. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study. Eur Arch Otorhinolaryngol 2019;276:3123–30

Carroll MP, Bulkhi AA, Lockey RF. Rhinitis and Sinusitis. Asthma, Allergic and Immunologic Diseases During Pregnancy, Cham: Springer International Publishing; 2019, p. 61–86. https://doi.org/10.1007/978-3-030-03395-8_5.

Carson P, Lyons M (2019) Severe rhinitis medicamentosa successfully treated with Rhinolight® endonasal UV Phototherapy Ir Med J 112(2):874 (PubMed MID: 30875167)

Casale M, Vella P, Moffa A, Sabatino L, Rinaldi V, Grimaldi V, Salvinelli F (2017) Topical hyaluronic acid in rhinitis medicamen-tosa: could our perspective be changed? J Biol Regul Homeost Agents 31(4 Suppl 2):55–62 (PubMed PMID: 29202563)

Chi, D. M. (2023). Treatment regimen for acute viral rhinitis in patients with a history of rhinitis medicamentosa. Asian Journal of Research in Medical and Pharmaceutical Sciences, 12(4), 139-144.

De Corso E, Mastrapasqua RF, Tricarico L, Settimi S, Di Cesare T, Mele DA, et al. Predisposing factors of rhinitis medicamentosa: What can influence drug discontinuation? Rhinology 2020;58:233–40. https://doi.org/10.4193/Rhin19.295.

Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: A nationwide survey of Canadian otolaryngologists. Journal of Otolaryngology - Head and Neck Surgery 2019;48. https://doi.org/10.1186/s40463-019-0392-1.

Kariri KI, Mokarbesh HM, Otaif AA, Mahzara NK, Otayf DA, Sumayli RA, et al. Knowledge and Patterns Related to Nasal Decongestant Use Among the General Population in the Jazan Region of Saudi Arabia: A Cross-Sectional Study. Cureus 2025. https://doi.org/10.7759/cureus.90924.

Kumar, R. S., Jain, M. K., Kushwaha, J. S., Patil, S., Patil, V., Ghatak, S., ... & Mittal, R. (2022). Efficacy and safety of fluticasone furoate and oxymetazoline nasal spray: a novel first fixed dose combination for the management of allergic rhinitis with nasal congestion. Journal of Asthma and Allergy, 783-792.

Li L-YJ, Wang S-Y, Tsai C-Y, Wu C-J. Rhinitis medicamentosa. BMJ Case Rep 2021;14:e247051. https://doi.org/10.1136/bcr-2021-247051.

Li W, Misra S, Harvey RJ, Kalish L. Long-term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery. Int Forum Allergy Rhinol 2023;1–9. Epub 2023 Jul 14

Liao J-Y, Hwang Y-L, Shih T-Y, Teng H-L, Huang C-Y. Radiofrequency Ablation of Inferior Turbinates With Posterior Nasal Nerve Neurolysis for Refractory Rhinitis Medicamentosa. Ear Nose Throat J 2025. https://doi.org/10.1177/01455613251364615.

Liao, J. Y., Hwang, Y. L., Shih, T. Y., Teng, H. L., & Huang, C. Y. (2025). Radiofrequency Ablation of Inferior Turbinates With Posterior Nasal Nerve Neurolysis for Refractory Rhinitis Medicamentosa. Ear, Nose & Throat Journal, 01455613251364615.

Margulis I, Jrbashyan J, Bitterman Fisher S, Feibish N, Stein N, Cohen-Kerem R. Rhinitis medicamentosa – comparing two treatment strategies: a retrospective analysis. J Laryngol Otol 2024;138:775–81. https://doi.org/10.1017/S0022215124000252.

Panwar, A., Kumar, A., & Sharma, G. A (2023). Clinical Study On The Effect Of Anu Taila Nasya And Shatyadi Vati In Vataja Pratishyaya With Special Reference To Allergic Rhinitis. Journal AYUSHDHARA.10 (6) 20-28.

Salama B, Elboraei Y, Alenezy A, A. Alrwaili MR, Shafi Alanazi A, Hamad Alanazi F, et al. Prevalence, Usage Patterns and Side Effects of Nasal Decongestants Among the General Population in Arar City: A Cross-Sectional Study. Journal of Pioneering Medical Sciences 2025;14:81–6. https://doi.org/10.47310/jpms2025140309.

Shushlyapina N, Lupyr A, Cherniakova A. Role of The Computer Capillaroscopy in The Assessment of Efficiency of The Inferior Turbinate Reduction in Patients With Rhinitis Medicamentosa. Scientific discoveries: projects, strategies and development (Volume 2), European Scientific Platform; 2019. https://doi.org/10.36074/25.10.2019.v2.06.

Tulaci KG, Yayman S, Arslan E, Canakci H, Tulaci T, Turan G, et al. Platelet‐Rich Plasma for Rhinitis Medicamentosa: A Promising Histopathological Study in an Animal Model. Otolaryngology–Head and Neck Surgery 2025;173:754–60. https://doi.org/10.1002/ohn.1303.

Zareen, S., Zareen, H., Ateeq, M., Rehman, H. U., Mohammad, W., & Achakzai, S. S. (2016). Xylometazoline: A tropical Nasal Decongestant and an extensive cause of Rhinitis medicamentosa (RM). Bull. Env. Pharmacol. Life Sci, 6, 28-32.

Downloads

Published

10-12-2025

How to Cite

[1]
N. N. R. Putri, F. Z. Istiwa, R. Aqila, R. S. P. Pratama, and S. Fithriyah, “Rintis Medikamentosa dalam Praktik Klinis: Diagnosis, Terapi, dan Pencegahan – A Narrative Review”, RIGGS, vol. 4, no. 4, pp. 4371–4378, Dec. 2025.